The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2016 | Transforming healthcare with Twitter: A physician’s perspective
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Navneet Majhail, MD, from Cleveland Clinic, Cleveland, OH, discusses Twitter as a way to engage colleagues and stay up-to-date with the latest medical information from journals and organizations, including the EBMT, European Hematology Association (EHA), American Society of Clinical Oncology (ASCO).
